April 7, 2022
Kizoo Portfolio Company Elastrin Therapeutics Inc. closes $10M Funding Round
Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform to develop therapeutics that render calcified tissue and organs supple again, has announced the closing of a $10 million funding round led by Kizoo Technology Capital, a early-stage investor in breakthrough rejuvenation technologies.